Correlation between TSC1 gene polymorphism and epilepsy
Autor: | Weiling Wang, Ye Li, Quanjiang Song, Guangyan Zhang, Xiuli Jiang, Jiajia Chen |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
congenital hereditary and neonatal diseases and abnormalities Cancer Research medicine.medical_specialty tuberous sclerosis complex 1 gene polymorphism homology modeling Locus (genetics) Biology 03 medical and health sciences Epilepsy 0302 clinical medicine Immunology and Microbiology (miscellaneous) Internal medicine Genotype medicine Gene Articles General Medicine medicine.disease SWISS-MODEL Blot 030104 developmental biology Real-time polymerase chain reaction medicine.anatomical_structure Endocrinology Immunology epilepsy Gene polymorphism TSC1 030217 neurology & neurosurgery |
Zdroj: | Experimental and Therapeutic Medicine |
ISSN: | 1792-1015 1792-0981 |
DOI: | 10.3892/etm.2017.5345 |
Popis: | The correlation between tuberous sclerosis complex 1 (TSC1) gene polymorphism and epilepsy was studied. In total, 38 patients with epilepsy treated in People's Hospital of Rizhao from May 2015 to June 2016 were selected as study subjects, as the observation group, 38 healthy people in the same period were selected as the control group. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to study the polymorphism of TSC1 gene in the above study subjects. The mRNA expression of TSC1 gene in the observation group and the control group was measured by fluorescence quantitative PCR, the expression of TSC1 protein in the control and observation group was measured by western blotting and ELISA. The polymorphisms of TSC1 gene in control group and observation group were analyzed by PCR-RFLP. There were three genotypes of TCS1 gene locus 142 in healthy population: CC (79.3%), CA (13.9%) and AA (6.8%), there were also three genotypes at locus 142 in the observation group: CC (21.3%), CA (26.4%) and AA (52.3%), there was significant difference in the genotypes at locus 142 between healthy population and the patients with epilepsy (P0.05). The expression of TSC1 gene was detected by western blot method. Western blotting showed no significant difference in TSC1 protein expression between the two groups (P>0.05). However, by determining the activity of TSC1 protein in the observation group and the control group by ELISA, it was found that TSC1 activity in healthy human body (8.95±2.41 U/ml) was much lower than that in the patients with epilepsy (29.27±4.06 U/ml), the difference was statistically significant (P |
Databáze: | OpenAIRE |
Externí odkaz: |